Who is the new director of cti biopharma? SEATTLE, Aug. 24, 2021 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC) today announced the appointment of Diane Parks to its Board of Directors. Ms. Parks has overseen the launch of numerous hematology and cancer therapies at large pharmaceutical and biotech companies, including… Read MoreWhat does ctcti biopharma do? CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally.Does cti biopharma have an nda? CTI BioPharma to Submit a New Drug Application (NDA) for the Accelerated Approval of Pacritinib for the Treatment of Myelofibrosis Patients with Severe Thrombocytopenia. SEATTLE, Sept. 29, 2020 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC) today announced that following a recent Pre-NDA meeting with the U.S.What time is the cti biopharma q1 2021 earnings call? CTI BioPharma (NASDAQ: CTIC)Q1 2021 Earnings CallJun 01, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, ladies and gentlemen. CTI BioPharma Corp. (Nasdaq: CTIC) today reported its financial results for the first quarter ended March 31, 2021.
Company Description: CTI Biopharma Corp. is located in Bainbridge Island, WA, United States and is part of the Scientific Research and Development Services Industry. CTI Biopharma Corp. has 1 employees at this location. There are 5 companies in ...